Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest research
Our research can be accessed for free under MIFID.
Find out more >
All research
Corporate research
- Update
- Monthly Report
- Sector Report
Tax advantaged research
- VCT
- EIS
- SEIS
- Initiation
- BR Review
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
List companies
Alliance Pharma Plc
Life Sciences
Entering the US market
By
Dr Martin Hall
19 Apr 2018
City of London Investment Group
Financials
Robust performance in volatile quarter
By
Dr Brian Moretta
19 Apr 2018
Avacta Group plc
Life Sciences
Commendable rate of progress
By
Dr Martin Hall
17 Apr 2018
genedrive Plc
Life Sciences
Progressing commercialisation plans
By
Dr Martin Hall
12 Apr 2018
Chamberlin Plc
Industrial
Trading healthy, technical issues improving
By
Paul Singer
12 Apr 2018
Life Sciences
Global Pharmaceuticals: 2017 industry statistics
By
Dr Martin Hall
11 Apr 2018
Building & Construction
UK Housebuilding Sector: 1Q 2018; and the weather forecast
09 Apr 2018
Tissue Regenix
Life Sciences
CellRight hits the right note
05 Apr 2018
Allergy Therapeutics plc
Life Sciences
Progressive development across portfolio
By
Dr Martin Hall
05 Apr 2018
Arbuthnot Banking Group Plc
Financials
2017: capital deployed, adding value
By
Mark Thomas
04 Apr 2018
Non-Standard Finance
Financials
Strong profit growth path confirmed
27 Mar 2018
Prev
1
...
71
72
73
74
75
...
84
Next
